Eva Pharma

EVA Pharma is an Egyptian pharmaceutical company that develops and manufactures medicines, including biologics and immunosuppressants, and operates research centres. The website lists a portfolio of 300+ products and 500+ products in the pipeline, across oncology, neuroscience, respiratory, cardiometabolic medicine, anti-infectives, ophthalmology, bone health, pain management, hepatology and sexual and reproductive health.

Its customers are patients, healthcare professionals and public health partners; the website describes a medical sales force of 1,000+ representatives and partnerships such as a 2024 voluntary licensing agreement with Gilead for lenacapavir and local insulin manufacturing with Lilly. The website does not describe its revenue model in detail. Its food supplement brand, Limitless Naturals, was founded in 2020.

The registry lists the company as founded in 2002, while the website timeline states that EVA Pharma was founded in Cairo in 1997; the group traces its roots to 1917. Headquarters are in Cairo, with manufacturing sites in Giza, 6th of October City and 10th of Ramadan City, a facility in Sudair Industrial City in Saudi Arabia, and the German affiliate Elbe Life Science in Hamburg. The website reports 5,000+ team members and open roles across operations, quality, software engineering, sales and finance.

Product: Branded medicines across oncology, neuroscience, respiratory, cardiometabolic and other therapeutic areas, biologics, contract development and manufacturing, and Limitless Naturals food supplements.